NEW YORK, NY / ACCESS Newswire / May 17, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading 3 key Ethereum price metrics suggest that ETH is gearing up for volatility.